Gikakis Nicolas 4

What Happened Nicolas Gikakis, a director of Aethlon Medical (AEMD), was granted 21,815 restricted stock units (RSUs) on 2026-04-17. The grant is reported at an imputed price of $2.29 per share for an aggregate value of $49,956. This is a compensation award (code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-04-17
• Form 4 filed: 2026-04-21 (filed timely)
• Transaction type/code: Award/Grant (A) — RSUs
• Quantity and value: 21,815 RSUs @ $2.29 = $49,956 aggregate
• Shares owned after transaction: Not disclosed in this filing
• Footnote: RSUs vest in four equal quarterly installments on 06/30/2026, 09/30/2026, 12/31/2026 and 03/31/2027, subject to continued service.

Context RSUs are a compensation/retention vehicle; the shares are not delivered until they vest, so this is not an immediate market purchase or sale. Because the award vests over time and is contingent on continued service, it represents future potential equity rather than current trading activity. The filing contains no indication of option exercises, sales, gifts, or a 10% owner transaction.